Literature DB >> 19609025

Development and validation of a gas chromatography-mass spectrometry method for the determination of imperatorin in rat plasma and tissue: application to study its pharmacokinetics.

Sicen Wang1, Qinhua Chen, Lan Wang, Langchong He.   

Abstract

A rapid and sensitive assay for the quantification of imperatorin in plasma and tissues has been developed. An analysis was performed by gas chromatography/mass spectrometry in the selected ion-monitoring mode. The main pharmacokinetic parameters obtained were T(max) = 1.23 +/- 0.26 h, C(max) = 0.95 +/- 0.38 microg/mL, AUC = 3.42 +/- 0.52 h microg/mL and K(a) = 1.34 +/- 0.18 h. The experimental results showed that imperatorin was easily absorbed, but its elimination was slow, from 3 to 12 h after oral administration. The concentrations of imperatorin in rat liver, kidney, lung, and heart were higher than those in other organs. To determine the free fraction in serum, samples were filtered using ultrafiltration membranes with a molecular weight cut-off of 10 kDa, and extracted using liquid-liquid extraction. The protein binding values in rat plasma, spontaneous hypertensive rat plasma, human plasma and human serum albumin were 84 +/- 3, 69 +/- 7, 81 +/- 7 and 75 +/- 3%, respectively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609025     DOI: 10.2116/analsci.25.869

Source DB:  PubMed          Journal:  Anal Sci        ISSN: 0910-6340            Impact factor:   2.081


  2 in total

Review 1.  Imperatorin-pharmacological meaning and analytical clues: profound investigation.

Authors:  Ewelina Kozioł; Krystyna Skalicka-Woźniak
Journal:  Phytochem Rev       Date:  2016-02-20       Impact factor: 5.374

2.  Preparation, Characterization, and Pharmacokinetic Evaluation of Imperatorin Lipid Microspheres and Their Effect on the Proliferation of MDA-MB-231 Cells.

Authors:  Xinli Liang; Xulong Chen; Guowei Zhao; Tao Tang; Wei Dong; Chunyan Wang; Jing Zhang; Zhenggen Liao
Journal:  Pharmaceutics       Date:  2018-11-16       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.